Trace amine-associated receptor 1 modulates dopaminergic activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 324, Issue 3, 2008, Pages 948-956

  Lindemann, Lothar ^a   Meyer, Claas Aiko ^b   Jeanneau, Karine ^a   Bradaia, Amyaouch ^c   Ozmen, Laurence ^a   Bluethmann, Horst ^b   Bettler, Bernhard ^c   Wettstein, Joseph G ^a   Borroni, Edilio ^a   Moreau, Jean Luc ^a   Hoener, Marius C ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMPHETAMINE; REGULATOR PROTEIN; TRACE AMINE ASSOCIATED RECEPTOR 1; TYRAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; DRUG MEGADOSE; ELECTROPHYSIOLOGY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONINERGIC SYSTEM; TEGMENTUM; WILD TYPE;

AMPHETAMINE; ANIMALS; DOPAMINE; DOPAMINE ANTAGONISTS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURONS; RECEPTORS, G-PROTEIN-COUPLED; VENTRAL TEGMENTAL AREA;

EID: 40849119967     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.132647     Document Type: Article

References (40)

1. Abrams JK, Johnson PL, Hollis JH, and Lowry CA (2004) Anatomic and functional topography of the dorsal raphe nucleus. Ann N Y Acad Sci 1018:46-57.
2. Aston-Jones G and Harris GC (2004) Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47:167-179.
3. Berry MD (2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90:257-271.
4. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, et al. (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A 98:8966-8971.
5. Branchek TA and Blackburn TP (2003) Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 3:90-97.
6. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, et al. (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181-1188.
7. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A, Markey CJ, Beshah E, Guroff JJ, Maxwell ME, et al. (1997) Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 43:1-8.
8. Cichon S, Schumacher J, Muller DJ, Hurter M, Windemuth C, Strauch K, Hemmer S, Schulze TG, Schmidt-Wolf G, Albus M, et al. (2001) A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 10:2933-2944.
9. de Curtis M and Pare D (2004) The rhinal cortices: a wall of inhibition between the neocortex and the hippocampus. Prog Neurobiol 74:101-110.
10. Deakin JF (2003) Depression and antisocial personality disorder: two contrasting disorders of 5HT function. J Neural Transm Suppl 64:79-93.
11. Eichenbaum H (2000) A cortical-hippocampal system for declarative memory. Nat Rev Neurosci 1:41-50.
12. Gabernet L, Pauly-Evers M, Schwerdel C, Lentz M, Bluethmann H, Vogt K, Alberati D, Mohler H, and Boison D (2005) Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression. Neurosci Lett 373:79-84.
13. Galceran J, Miyashita-Lin EM, Devaney E, Rubenstein JL, and Grosschedl R (2000) Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Development 127:469-482.
14. Geracitano R, Federici M, Prisco S, Bernardi G, and Mercuri NB (2004) Inhibitory effects of trace amines on rat midbrain dopaminergic neurons. Neuropharmacology 46:807-814.
15. Hatcher JP, Jones DN, Rogers DC, Hatcher PD, Reavill C, Hagan JJ, and Hunter AJ (2001) Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav Brain Res 125:43-47.
16. Irwin S (1968) Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13:222-257.
17. Joyner AL (1999) Gene Targeting, 2nd ed. The Practical Approach Series, Oxford University Press, New York.
18. Kalderon D, Roberts BL, Richardson WD, and Smith AE (1984) A short amino acid sequence able to specify nuclear location. Cell 39:499-509.
19. King GR and Ellinwood EH (1992) Amphetamines and other stimulants, in Substance Abuse: A Comprehensive Textbook (Lowinson JH, Ruiz P, Millman RB, and Langrod JG eds). Lippincott Williams & Wilkins, Baltimore, MD.
20. Liberles SD and Buck LB (2006) A second class of chemosensory receptors in the olfactory epithelium. Nature 442:645-650.
21. Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, and Hoener MC (2005) Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85:372-385.
22. Lindemann L and Hoener MC (2005) A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol Sci 26:274-281.
23. + channels. Eur J Biochem 267:5830-5836.
24. McGinty D, Gong H, Suntsova N, Alam MN, Methippara M, Guzman-Marin R, and Szymusiak R (2004) Sleep-promoting functions of the hypothalamic median preoptic nucleus: inhibition of arousal systems. Arch Ital Biol 142:501-509.
25. Nathan SV, Griffith QK, McReynolds JR, Hahn EL, and Roozendaal B (2004) Basolateral amygdala interacts with other brain regions in regulating glucocorticoid effects on different memory functions. Ann N Y Acad Sci 1032:179-182.
26. Parker EM and Cubeddu LX (1988) Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J Pharmacol Exp Ther 245:199-210.
27. Philips SR (1984) Analysis of trace amines: endogenous levels and the effects of various drugs on tissue concentrations in the rat, in Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects (Boulton AA, Baker GB, Dewhurst WG and Sandler M eds), Humana Press, Clifton, NJ.
28. Raiteri M, Cerrito F, Cervoni AM, Del Carmine R, Ribera MT, and Levi G (1978) Studies on dopamine uptake and release in synaptosomes. Adv Biochem Psychopharmacol 19:35-56.
29. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, and Patel YC (2000) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154-157.
30. Saavedra JM and Axelrod J (1976) Octopamine as a putative neurotransmitter. Adv Biochem Psychopharmacol 15:95-110.
31. Sabelli HC, Borison RL, Diamond BI, Havdala HS, and Narasimhachari N (1978) Phenylethylamine and brain function. Biochem Pharmacol 27:1707-1711.
32. Schmitz Y, Benoit-Marand M, Gonon F, and Sulzer D (2003) Presynaptic regulation of dopaminergic neurotransmission. J Neurochem 87:273-289.
33. Sotnikova TD, Budygin EA, Jones SR, Dykstra LA, Caron MG, and Gainetdinov RR (2004) Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine. J Neurochem 91:362-373.
34. Vacher CM, Gassmann M, Desrayaud S, Challet E, Bradaia A, Hoyer D, Waldmeier P, Kaupmann K, Pevet P, and Bettler B (2006) Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice. J Neurochem 97:979-991.
35. van der Vegt BJ, Lieuwes N, Cremers TI, de Boer SF, and Koolhaas JM (2003) Cerebrospinal fluid monoamine and metabolite concentrations and aggression in rats. Horm Behav 44:199-208.
36. Vladimirov V, Thiselton DL, Kuo P-H, McClay J, Fanous A, Wormley B, Vittum J, Ribble R, Moher B, van den Oord E, et al. (2007) A region of 35 kb containing the trace amine associated receptor 6 (TAAR6) gene is associated with schizophrenia in the Irish study of high-density schizophrenia families. Mol Psychiatry 12:842-853.
37. Walker DL, Toufexis DJ, and Davis M (2003) Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463:199-216.
38. Wolinsky TD, Swanson CJ, Smith KE, Zhong H, Borowsky B, Seeman P, Branchek T, and Gerald CP (2007) The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav 6:628-639.
39. Yamaguchi T, Sheen W, and Morales M (2007) Glutamatergic neurons are present in the rat ventral tegmental area. Eur J Neurosci 25:106-118.
40. Yaniv D, Desmedt A, Jaffard R, and Richter-Levin G (2004) The amygdala and appraisal processes: stimulus and response complexity as an organizing factor. Brain Res Rev 44:179-186.